Table 6. KIR2DL3 and Group 1 HLA-C Associations in Treatment Cohort.
SVR n (%) | No SVR n (%) | P Value (Pc) | OR (95% CI) | |
---|---|---|---|---|
Number of patients | 107 | 101 | ||
2DL3+Cw*01 | 6 (5.6) | 6 (5.9) | 0.92 | |
2DL3+Cw*03 | 24 (22.4) | 8 (7.9) | 0.004 (0.03) | 3.4 (1.5-8.7) |
2DL3+Cw*07 | 48 (44.9) | 45 (44.6) | 0.96 | |
2DL3+Cw*08 | 13 (12.1) | 6 (5.9) | 0.12 | |
2DL3+Cw*12 | 13 (12.1) | 4 (4.0) | 0.03 (>0.1) | 3.4 (1.0-14.6) |
2DL3+Cw*14 | 4 (3.7) | 2 (2.0) | 0.57 | |
2DL3+Cw*16 | 5 (4.7) | 9 (8.9) | 0.22 |